Matthew O'Brien
Stock Analyst at Piper Sandler
(0.27)
# 4,517
Out of 5,004 analysts
1282
Total ratings
40.4%
Success rate
-3.4%
Average return
Main Sectors:
Stocks Rated by Matthew O'Brien
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Reiterated: Hold | $4 | $2.70 | +48.15% | 25 | Sep 22, 2026 | |
| KMTS Kestra Medical Technologies | Reiterated: Buy | $30 | $27.14 | +10.54% | 8 | Sep 15, 2026 | |
| TMDX TransMedics Group | Reiterated: Buy | $90 → $100 | $85.29 | +17.25% | 42 | Sep 11, 2026 | |
| ATRC AtriCure | Rated: Buy | $50 → $60 | $58.38 | +2.77% | 43 | Aug 27, 2026 | |
| HTFL HeartFlow | Reiterated: Buy | $38 → $45 | $49.17 | -8.48% | 5 | Aug 14, 2026 | |
| MDT Medtronic | Reiterated: Hold | $85 | $88.64 | -4.11% | 62 | Aug 14, 2026 | |
| OBIO Orchestra BioMed Holdings | Reiterated: Buy | $9 → $10 | $5.95 | +68.07% | 10 | Aug 11, 2026 | |
| TELA TELA Bio | Reiterated: Hold | $1 | $1.26 | -20.63% | 27 | Aug 11, 2026 | |
| GMED Globus Medical | Reiterated: Buy | $100 | $74.52 | +34.19% | 56 | Aug 7, 2026 | |
| SI Shoulder Innovations | Reiterated: Buy | $19 → $25 | $16.99 | +47.15% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $15.72 | +109.92% | 35 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $15.10 | +19.21% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $10.12 | +38.34% | 38 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $25 | $22.55 | +10.86% | 30 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $25 | $17.20 | +45.35% | 20 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $18.59 | +34.48% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $97 → $127 | $126.34 | +0.52% | 15 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 → $95 | $86.62 | +9.67% | 67 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $420 → $390 | $272.36 | +43.19% | 54 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $21.51 | -7.02% | 12 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $39 → $45 | $45.38 | -0.84% | 42 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $210 | $136.13 | +54.26% | 38 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $65 | $43.92 | +48.00% | 61 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $19.98 | -19.92% | 2 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3 | $0.195 | +1,438.46% | 1 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $330 → $374 | $318.89 | +17.28% | 18 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $91.04 | - | 42 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 | $8.93 | n/a | 24 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $20.51 | n/a | 12 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $245 → $140 | $122.07 | n/a | 26 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $11 | $11.84 | n/a | 20 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 → $180 | $154.43 | n/a | 62 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $4.5 → $2 | $2.96 | n/a | 26 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 → $3 | $0.5573 | n/a | 7 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $44 | $16.12 | n/a | 38 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $11 | $0.8198 | n/a | 7 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $90 | $0.0002 | n/a | 15 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $10 | $2.74 | n/a | 24 | Nov 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $82 | $23.37 | n/a | 16 | Sep 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 → $79 | $87.50 | n/a | 25 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 | $22.73 | n/a | 14 | Jul 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 | $3.21 | n/a | 6 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $370 → $435 | $55.38 | n/a | 30 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $0.1537 | n/a | 10 | Jan 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $73 | $76.63 | n/a | 38 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $7 | $0.000001 | n/a | 8 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $258 → $345 | $146.78 | n/a | 35 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $600 → $633 | $405.18 | n/a | 27 | Sep 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $3 | $6.99 | n/a | 3 | Jan 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $4.67 | n/a | 9 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 → $96 | $5.36 | n/a | 8 | Nov 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 → $69 | $9.40 | n/a | 9 | Aug 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 → $70 | $222.00 | n/a | 8 | Aug 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.3757 | n/a | 2 | Aug 14, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.98 | n/a | 2 | May 8, 2012 |
CVRx, Inc.
Sep 22, 2026
Reiterated: Hold
Price Target: $4
Current: $2.70
Upside: +48.15%
Kestra Medical Technologies
Sep 15, 2026
Reiterated: Buy
Price Target: $30
Current: $27.14
Upside: +10.54%
TransMedics Group
Sep 11, 2026
Reiterated: Buy
Price Target: $90 → $100
Current: $85.29
Upside: +17.25%
AtriCure
Aug 27, 2026
Rated: Buy
Price Target: $50 → $60
Current: $58.38
Upside: +2.77%
HeartFlow
Aug 14, 2026
Reiterated: Buy
Price Target: $38 → $45
Current: $49.17
Upside: -8.48%
Medtronic
Aug 14, 2026
Reiterated: Hold
Price Target: $85
Current: $88.64
Upside: -4.11%
Orchestra BioMed Holdings
Aug 11, 2026
Reiterated: Buy
Price Target: $9 → $10
Current: $5.95
Upside: +68.07%
TELA Bio
Aug 11, 2026
Reiterated: Hold
Price Target: $1
Current: $1.26
Upside: -20.63%
Globus Medical
Aug 7, 2026
Reiterated: Buy
Price Target: $100
Current: $74.52
Upside: +34.19%
Shoulder Innovations
Aug 7, 2026
Reiterated: Buy
Price Target: $19 → $25
Current: $16.99
Upside: +47.15%
Aug 7, 2026
Reiterated: Buy
Price Target: $33
Current: $15.72
Upside: +109.92%
Aug 6, 2026
Reiterated: Buy
Price Target: $18
Current: $15.10
Upside: +19.21%
Aug 5, 2026
Reiterated: Buy
Price Target: $14
Current: $10.12
Upside: +38.34%
Aug 5, 2026
Reiterated: Buy
Price Target: $22 → $25
Current: $22.55
Upside: +10.86%
Aug 5, 2026
Reiterated: Buy
Price Target: $35 → $25
Current: $17.20
Upside: +45.35%
Aug 4, 2026
Reiterated: Buy
Price Target: $25
Current: $18.59
Upside: +34.48%
Aug 3, 2026
Downgraded: Hold
Price Target: $97 → $127
Current: $126.34
Upside: +0.52%
Jul 31, 2026
Reiterated: Buy
Price Target: $88 → $95
Current: $86.62
Upside: +9.67%
Jul 31, 2026
Reiterated: Buy
Price Target: $420 → $390
Current: $272.36
Upside: +43.19%
Jul 30, 2026
Reiterated: Buy
Price Target: $20
Current: $21.51
Upside: -7.02%
Jul 30, 2026
Reiterated: Hold
Price Target: $39 → $45
Current: $45.38
Upside: -0.84%
Jun 15, 2026
Reiterated: Buy
Price Target: $210
Current: $136.13
Upside: +54.26%
Jun 12, 2026
Reiterated: Buy
Price Target: $90 → $65
Current: $43.92
Upside: +48.00%
Jun 4, 2026
Reiterated: Hold
Price Target: $16
Current: $19.98
Upside: -19.92%
Apr 14, 2026
Initiated Coverage: Buy
Price Target: $3
Current: $0.195
Upside: +1,438.46%
Jan 15, 2026
Downgraded: Hold
Price Target: $330 → $374
Current: $318.89
Upside: +17.28%
Oct 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $91.04
Upside: -
May 9, 2025
Reiterated: Hold
Price Target: $3.5
Current: $8.93
Upside: n/a
May 8, 2025
Reiterated: Hold
Price Target: $16
Current: $20.51
Upside: n/a
Feb 28, 2025
Downgraded: Hold
Price Target: $245 → $140
Current: $122.07
Upside: n/a
Feb 14, 2025
Reiterated: Hold
Price Target: $12 → $11
Current: $11.84
Upside: n/a
Jan 27, 2025
Reiterated: Buy
Price Target: $140 → $180
Current: $154.43
Upside: n/a
Aug 9, 2024
Rated: Hold
Price Target: $4.5 → $2
Current: $2.96
Upside: n/a
Nov 10, 2023
Reiterated: Hold
Price Target: $3.5 → $3
Current: $0.5573
Upside: n/a
Jun 26, 2023
Reiterated: Hold
Price Target: $55 → $44
Current: $16.12
Upside: n/a
Nov 14, 2022
Reiterated: Buy
Price Target: $9 → $11
Current: $0.8198
Upside: n/a
Nov 14, 2022
Reiterated: Buy
Price Target: $10 → $90
Current: $0.0002
Upside: n/a
Nov 9, 2021
Reiterated: Buy
Price Target: $12 → $10
Current: $2.74
Upside: n/a
Sep 2, 2021
Reiterated: Hold
Price Target: $82
Current: $23.37
Upside: n/a
Jul 30, 2021
Reiterated: Buy
Price Target: $62 → $79
Current: $87.50
Upside: n/a
Jul 6, 2021
Reiterated: Buy
Price Target: $70
Current: $22.73
Upside: n/a
Mar 23, 2021
Reiterated: Hold
Price Target: $3.5
Current: $3.21
Upside: n/a
Feb 11, 2021
Reiterated: Buy
Price Target: $370 → $435
Current: $55.38
Upside: n/a
Jan 27, 2021
Reiterated: Hold
Price Target: $7
Current: $0.1537
Upside: n/a
Jan 12, 2021
Reiterated: Buy
Price Target: $70 → $73
Current: $76.63
Upside: n/a
Jan 12, 2021
Reiterated: Buy
Price Target: $4 → $7
Current: $0.000001
Upside: n/a
Jul 23, 2020
Reiterated: Buy
Price Target: $258 → $345
Current: $146.78
Upside: n/a
Sep 25, 2019
Reiterated: Buy
Price Target: $600 → $633
Current: $405.18
Upside: n/a
Jan 7, 2018
Reiterated: Buy
Price Target: $10 → $3
Current: $6.99
Upside: n/a
Dec 13, 2017
Reiterated: Buy
Price Target: $18
Current: $4.67
Upside: n/a
Nov 7, 2017
Reiterated: Hold
Price Target: $90 → $96
Current: $5.36
Upside: n/a
Aug 9, 2017
Reiterated: Buy
Price Target: $73 → $69
Current: $9.40
Upside: n/a
Aug 2, 2017
Reiterated: Hold
Price Target: $65 → $70
Current: $222.00
Upside: n/a
Aug 14, 2014
Reiterated: Buy
Price Target: n/a
Current: $0.3757
Upside: n/a
May 8, 2012
Downgraded: Hold
Price Target: n/a
Current: $9.98
Upside: n/a